IQV IQVIA

Q1 2025 10-Q

Filed: May 6, 2025Period ending Mar 31, 2025

Industrials

Services-Commercial Physical & Biological ResearchSEC EDGAR

IQVIA (IQV) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 6, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• New regulatory tax risk: EU OECD Pillar Two minimum 15% tax implemented 2024; no material impact YTD 2025 but ongoing evaluation amid global tax law changes
• Updated financial risk: Raised equity repurchase authorization by $2B to total $13.725B; repurchased $425M of stock in Q1 2025 vs prior periods

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$3.8B

Net Income

$249M

Operating Margin

13.0%

Net Margin

6.5%

Source: XBRL data from IQVIA Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other IQVIA Quarterly Reports

Q3 2025 10-Q

Get deeper insights on IQVIA

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.